Page 151 - 南京医科大学自然版

第45卷第10期 吴佳懿，朱春富，徐克群. 乳酸代谢在胰腺癌中的研究进展［J］.
2025年10月 南京医科大学学报（自然科学版），2025，45（10）：1513-1520 ·1519 ·

［2］ DUAN H，LI L，HE S. Advances and prospects in the tein kinase 2 suppresses proliferation and aerobic glycol⁃
treatment of pancreatic cancer［J］. Int J Nanomedicine， ysis via ERK/cMyc axis in pancreatic cancer［J］. Cell Pro⁃

2023，18：3973-3988 lif，2019，52（3）：e12603
［3］ WARBURG O. On the origin of cancer cells［J］. Science， ［17］HU Q，QIN Y，JI S，et al. MTAP Deficiency⁃induced meta⁃
1956，123（3191）：309-314 bolic reprogramming creates a vulnerability to cotargeting
［4］ PEREZ⁃TOMAS R，PEREZ⁃GUILLEN I. Lactate in the tu⁃ de novo purine synthesis and glycolysis in pancreatic can⁃
mor microenvironment：an essential molecule in cancer cer［J］. Cancer Res，2021，81（19）：4964-4980
progression and treatment［J］. Cancers（Basel），2020，12 ［18］HUI S，GHERHUROVICH J M，MORSCHER R J，et al.
（11）：3244 Glucose feeds the TCA cycle via circulating lactate［J］.
［5］ ZENG Y，HUANG Y，TAN Q，et al. Influence of lactate in Nature，2017，551（7678）：115-118
resistance to anti⁃PD⁃1/PD⁃L1 therapy：mechanisms and ［19］WANG J X，CHOI S Y C，NIU X，et al. Lactic acid and an
clinical applications（review）［J］. Mol Med Rep，2025，31 acidic tumor microenvironment suppress anticancer im⁃
（2）：48 munity［J］. Int J Mol Sci，2020，21（21）：8363
［6］ SUN K，ZHANG X，SHI J，et al. Elevated protein lacty⁃ ［20］KOCIANOVA E，PIATRIKOVA V，GOLIAS T. Revisiting
lation promotes immunosuppressive microenvironment the warburg effect with focus on lactate［J］. Cancers（Ba⁃
and therapeutic resistance in pancreatic ductal adenocar⁃ sel），2022，14（24）：6028
cinoma［J］. J Clin Invest，2025，135（7）：e187024 ［21］XING W，LI X，ZHOU Y，et al. Lactate metabolic path⁃
［7］ PENG T，SUN F，YANG J，et al. Novel lactylation⁃related way regulates tumor cell metastasis and its use as a new
signature to predict prognosis for pancreatic adenocarcino⁃ therapeutic target［J］. Explor Med，2023，4：541-559
ma［J］. World J Gastroenterol，2024，30（19）：2575-2602 ［22］KITAMURA F，SEMBA T，YASUDA⁃YOSHIHARA N，et
［8］ SHARMA D，SINGH M，RANI R. Role of LDH in tumor al. Cancer⁃associated fibroblasts reuse cancer⁃derived lac⁃
glycolysis：regulation of LDHA by small molecules for tate to maintain a fibrotic and immunosuppressive micro⁃
cancer therapeutics［J］. Semin Cancer Biol，2022，87： environment in pancreatic cancer［J］. JCI Insight，2023，8
184-195 （20）：e163022
［9］ HAYES C，DONOHOE C L，DAVERN M，et al. The onco⁃ ［23］LI X，YANG Y，ZHANG B，et al. Lactate metabolism in
genic and clinical implications of lactate induced immu⁃ human health and disease［J］. Signal Transduct Target
nosuppression in the tumour microenvironment［J］. Can⁃ Ther，2022，7（1）：305
cer Lett，2021，500：75-86 ［24］CHENG C，TAN H，WANG N，et al. Functional inhibition
［10］CHEN J，HUANG Z，CHEN Y，et al. Lactate and lacty⁃ of lactate dehydrogenase suppresses pancreatic adenocar⁃
lation in cancer［J］. Signal Transduct Target Ther，2025， cinoma progression［J］. Clin Transl Med，2021，11（6）：
10（1）：38 e467
［11］BYUN J. Tumor lactic acid：a potential target for cancer ［25］LIU X，LI S，CUI Q，et al. Activation of GPR81 by lactate
therapy［J］. Arch Pharm Res，2023，46（2）：90-110 drives tumour⁃induced cachexia［J］. Nat Metab，2024，6
［12］JIANG L，ZHAO L，BI J，et al. Glycolysis gene expression （4）：708-723
profilings screen for prognostic risk signature of hepato⁃ ［26］CHEN S，XU Y，ZHUO W，et al. The emerging role of
cellular carcinoma［J］. Aging（Albany NY），2019，11 lactate in tumor microenvironment and its clinical rele⁃
（23）：10861-10882 vance［J］. Cancer Lett，2024，590：216837
［13］LIANG C，SHI S，QIN Y，et al. Localisation of PGK1 de⁃ ［27］ZHENG Q，XIE Y，XU L，et al. LDHA as a predictive bio⁃
termines metabolic phenotype to balance metastasis and marker and its association with the infiltration of immune
proliferation in patients with SMAD4⁃negative pancreatic cells in pancreatic adenocarcinoma［J］. J Gastrointest On⁃
cancer［J］. Gut，2020，69（5）：888-900 col，2024，15（4）：1746-1759
［14］WU H，FU M，WU M，et al. Emerging mechanisms and ［28］MU X，SHI W，XU Y，et al. Tumor⁃derived lactate induc⁃
promising approaches in pancreatic cancer metabolism［J］. es M2 macrophage polarization via the activation of the
Cell Death Dis，2024，15（8）：553 ERK/STAT3 signaling pathway in breast cancer［J］. Cell
［15］QIN Y，HU Q，XU J，et al. PRMT5 enhances tumorigenici⁃ Cycle，2018，17（4）：428-438
ty and glycolysis in pancreatic cancer via the FBW7/cMyc ［29］HE Y，HUANG Y，PENG P，et al. Lactate and lactylation
axis［J］. Cell Commun Signal，2019，17（1）：30 in gastrointestinal cancer：current progress and perspec⁃
［16］QIN Y，HU Q，JI S，et al. Homeodomain⁃interacting pro⁃ tives（review）［J］. Oncol Rep，2025，53（1）：6